OWCP - OWC Pharmaceutical Research Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
50
Operating Expense
3,764
4,296
4,554
2,148
Operating Income
-3,764
-4,296
-4,554
-2,098
Net Non Operating Interest Income Expense
-9
-826
-4.725
-189.255
Other Income Expense
5,113
-5,136
-
-
Pretax Income
1,340
-10,258
-4,558
-2,287
Net Income Common Stockholders
-2,289
-12,705
-4,558
-2,287
Diluted NI Available to Com Stockholders
-1,214
-12,705
-4,558
-2,287
Basic EPS
-
0
0
0
Diluted EPS
-
0
0
0
Basic Average Shares
-
148,066
145,204
96,362
Diluted Average Shares
-
148,066
145,204
96,362
Total Operating Income as Reported
-
-4,296
-4,554
-2,098
Total Expenses
3,764
4,296
4,554
2,148
Net Income from Continuing & Discontinued Operation
1,340
-10,258
-4,558
-2,287
Normalized Income
-2,597
-5,122
-4,558
-2,287
Interest Expense
-
3
-
-
Net Interest Income
-9
-826
-4.725
-189.255
EBIT
-9,723
-10,255
-4,554
-2,098
EBITDA
-9,714
-
-
-
Reconciled Depreciation
9
7
8.341
9.686
Net Income from Continuing Operation Net Minority Interest
1,340
-10,258
-4,558
-2,287
Total Unusual Items Excluding Goodwill
5,113
-5,136
-
-
Total Unusual Items
5,113
-5,136
-
-
Normalized EBITDA
-14,827
-5,112
-4,545
-2,088
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
1,176
0
0
0